ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,657, issued on Jan. 13, was assigned to The General Hospital Corp. (Boston) and The Brigham and Women's Hospital Inc. (Boston).

"Therapeutic targeting of Cadherin 11 in cancer" was invented by Daniel A. Haber (Chestnut Hill, Mass.), Michael Brenner (Newton, Mass.), Shyamala Maheswaran (Lexington, Mass.), David T. Ting (Dover, Mass.) and Douglas Micalizzi (Somerville, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods, uses, and compositions for the treatment of cancer (e.g., a breast cancer or a pancreatic cancer). More specifically, the invention concerns the treatment of patients having cancer for the the...